DFE Pharma produces and markets excipients for oral solid dose and dry powder inhalation formulations. It is one of the leading companies in excipients. Its customers are pharmaceutical companies, operating globally, regionally and locally. The company is headquartered in Germany (Goch) and has production facilities in Germany, New Zealand, India and the Netherlands. DFE Pharma operates in more than 100 countries and has sales offices in Germany, the United States, Brazil, India, Singapore, China and Japan.
DFE Pharma is a 50-50 joint venture between Royal FrieslandCampina (the Netherlands) and Fonterra (New Zealand). The company is consolidated in the financial statements of Royal FrieslandCampina.
DFE Pharma, the pursuit of excipient excellence